Zoetis (ZTS) Long-Term Deferred Tax (2012 - 2026)
Zoetis (ZTS) reported Long-Term Deferred Tax of $591.0 million for Q1 2026, up 11.51% year-over-year from $530.0 million in Q1 2025, and down 7.08% quarter-over-quarter from $636.0 million in Q4 2025.
Zoetis (ZTS) Long-Term Deferred Tax (2012 - 2026) Analysis & Trends
Zoetis (ZTS) has 15 years of Long-Term Deferred Tax data on file, last reported at $591.0 million in Q1 2026.
- Long-Term Deferred Tax for Q1 2026 came in at $591.0 million, up 11.51% year-over-year; the trailing twelve-month figure through Mar 2026 was $591.0 million (up 11.51% YoY), and the FY2025 annual result was $636.0 million, up 17.78% from the prior year.
- Long-Term Deferred Tax slipped to $591.0 million in Q1 2026 per ZTS's latest filing, from $636.0 million in the prior quarter.
- Over five years, Long-Term Deferred Tax peaked at $636.0 million in Q4 2025 and troughed at $103.0 million in Q1 2022.
- A 5-year average of $338.5 million and a median of $232.0 million in 2024 frame the typical range for Long-Term Deferred Tax.
- The sharpest annual moves came in 2022 and 2024: Long-Term Deferred Tax advanced 0.91% in 2022, then surged 162.14% in 2024.
- A 5-year view of Long-Term Deferred Tax shows it stood at $173.0 million in 2022, then advanced by 19.08% to $206.0 million in 2023, then surged by 162.14% to $540.0 million in 2024, then increased by 17.78% to $636.0 million in 2025, then slipped by 7.08% to $591.0 million in 2026.
- Business Quant data shows ZTS's Long-Term Deferred Tax at $591.0 million in Q1 2026, $636.0 million in Q4 2025, and $587.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 591.00 Mn |
| Dec 31, 2025 | 636.00 Mn |
| Sep 30, 2025 | 587.00 Mn |
| Jun 30, 2025 | 617.00 Mn |
| Mar 31, 2025 | 530.00 Mn |
| Dec 31, 2024 | 540.00 Mn |
| Sep 30, 2024 | 409.00 Mn |
| Jun 30, 2024 | 366.00 Mn |
| Mar 31, 2024 | 232.00 Mn |
| Dec 31, 2023 | 206.00 Mn |
| Sep 30, 2023 | 190.00 Mn |
| Jun 30, 2023 | 192.00 Mn |
| Mar 31, 2023 | 161.00 Mn |
| Dec 31, 2022 | 173.00 Mn |
| Sep 30, 2022 | 111.00 Mn |
| Jun 30, 2022 | 110.00 Mn |
| Mar 31, 2022 | 103.00 Mn |
| Dec 31, 2021 | 100.00 Mn |
| Sep 30, 2021 | 110.00 Mn |
| Jun 30, 2021 | 103.00 Mn |